© Copyright Nostre Net
The microbial
products market is influenced by factors such as increased disease
prevalence, increased demand for health nutrients such as vitamins, increasing
amounts of cancer, increased demand for microbial diagnostic products,
increased recommended industrial lifestyle for many of these products. The
pressure on profit due to fierce competition, the secrets of the fermentation
process, low-quality producers operating in unfamiliar places are also some of
the factors driving. Emerging demand for high-quality drugs and the growing
application of DNA technology stimulates the growth of high-quality ultra-pure
solvents, which in turn stimulate the microbial market. Growing demand for
diagnostic tests with high sensitivity and selectivity is another cause of the
growing market for microbial products.
The global market is also expected to progress owing to
growing collaboration among the major players and their emphasis on product
development that can be applied in every condition.
Get Sample Report
@https://www.marketresearchfuture.com/sample_request/765
Competitive Players
The industry giants that are backing the operation of global
microbial products are Amgen Inc., Merck & Co., Inc., Valent BioSciences
Corp., Ajinomoto Co.Inc., Kyowa Hakko Bio Co., GlaxoSmithKline plc, Pfizer
Inc., bioMérieux SA, Novartis AG, NovaDigm Therapeutics, Sanofi S.A, Ltd and others.
Growing inclination mergers and acquisitions to increase the competitiveness in
the global market is one of key trends adopted by the industry players to
remain in the race.
Market Segmentation
The global microbial products market is segmented by type,
source, application, and end-user.
Based on the types, the market is segmented into
polysaccharides enzymes, nutrients such as amino acids, nucleotides, vitamins
and organic acids, others, chemotherapy, antibiotics, vaccines, and so on.
Based on the source, the market is divided into bacteria,
viruses, fungi, and others.
Based on applications, the market is classified in the
pharmaceutical, diagnostic, biotechnology, and other fields.
Based on end-users, the market is bifurcated into the
pharmaceutical and biotechnology industry, hospitals and clinics, diagnostic,
research and academic laboratories, and so on.
Regional Insights
The US holds the major market share due to favorable
insurance penetration, an excellent reimbursement scenario, and higher healthcare
spending. High per capita consumption of microbial products as a result of high
per capita income is also the driving force of the market. Faster acceptance of
new technologies by the US market is also a major driver of the global
microbial market. Europe, following the US, is the second-largest market owing
to its large disposable income and growing consumer habits.
The Asia Pacific region is expected to offer the maximum
potential for the future. India and China would lead to this initiative. The
market in the Middle East and Africa is led by the Gulf states such as Saudi
Arabia and the United Arab Emirates. African regions are expected to experience
moderate growth due to poor economic and political conditions and low
penetration of health services.
Recent Updates
Corteva Agriscience and MicroMGx announced a collaboration
aimed at providing farmers with a wider range of new microbial-based crop
protection products. Under the agreement, MicroMGx will apply its
metabologenomics platform to accelerate the identification of new starting
points for natural products. For the first time in the agricultural sector,
Corteva will use these starting points to discover and develop crop protection
solutions of natural origin. Metabolology modernizes the discovery of natural
products by merging genomics and mass spectrometry data in a way that
facilitates more targeted identification of molecules.
Browse Complete
Report Details @ https://www.marketresearchfuture.com/reports/microbial-products-market-765
About US:
Market Research Future (MRFR), enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Market Overview
Each year the death toll of women
is increasingly becoming high due to complications during pregnancy. The number
is seen to stand at a much more reduced rate today as compared to years back.
The reason behind this are the continuous government initiatives being
undertaken. The government across the globe is trying to aid pregnant women to
ensure better health of both the mother and baby. The best example of such an
initiative can be seen taken by the UNICEF (India). The program named as Janani
Shishu Suraksha Karyakaram (JSSK) scheme provides free maternity service across
India. Such services are offered to maternal mothers to accelerate the number
of emergency referral systems and maternal death audits. Every year near a vast
population of women succumb to death due to complications during maternity
period. The number of deaths associated with this complication is controlled by
the WHO, CDC and UNICEF programs. Adolescent women are at the risk of such
complications during pregnancy, thereby these women are provided with various
health services to tackle these complications. Additionally, post pregnancy
services are also provided to them.
The Maternal
Health Market is growing at a steady pace. The complications are seen to be
more prevalent in the elderly pregnant ladies. The complications are of extremely
high risk and cab occur due to changing lifestyle and trends. The habits of
smoking and drinking is considered to be one of the major issue behind such
complications. In developed nations and urban developing countries, a number of
women smoking population is high. In developing countries, women who are
between the age of 15-19 are reportedly found dead because of various
complications during pregnancy and child birth.
The global maternal health marketwas
analyzed by Market Research Future (MRFR) and it was projected that a healthy
CAGR of 7% will be attained by the market over the forecast period of 2017 to
2023. The valuation of the maternal
health marketwas further stated to surpass its previous
valuation with the revenue pool getting wider.
Get Sample Report
@https://www.marketresearchfuture.com/sample_request/732
Global Maternal Health Market
Players:
Some of the players who work
maternal health are, Agile Therapeutics (USA), Fuji Latex Co(Japan), Okamoto
industries, Reckitt Benckiser Group Plc.(UK), Sanofi (India), Johnson and
Johnson(USA).
Market Segmentation
The global maternal health markethas been
segmented in terms of type of the pregnancy, complications, and risks in
pregnancy.
By types, the market includes Tubal,
Intrauterine, Ectopic, and others.
By risk, the market divides into
high risk and molar risk.
By complications, the market segments
into gestational diabetes, premature labor and birth, miscarriage,
preeclampsia, placenta previa and others. The miscarriage segments further into
complete, threatened, inevitable, and incomplete.
Regional Analysis
The global maternal health marketis
geographically distributed across the following key regions: Asia Pacific,
North America, Europe, and the Middle East & Africa.
The deaths of women across the
globe are increasingly high due to various complications during the period of pregnancy.
The market for maternal health is divided into four primary geographical
regions as stated above. Furthermore, the regions are divided primarily into
various developed and developing nations falling under this regions. The deaths
of women have increased considerably in Americas despite the availability of
advanced medicine and technology over past the 25 years and more. The reason
behind this is due to chronic health concerns like heart conditions, blood
pressure, bleeding and many more complications. The number of deaths is
considerably high in developing regions across the globe, like Asia Pacific and
the Middle East & Africa, as marriages are done at a comparatively young
age herein.
Competitive Landscape
Agile therapeutics is women healthcare company, have announced the report
of the additional phase 3 SECURE study research report for women healthcare.
The Phase 3 SECURE trial of its investigational low-dose combination hormone
contraceptive patch of Twirla. This product will be used for the bleeding in
women.
Johnson and Johnson is actively working with the Millennium Development
Goals (MDG). The millennium Development Goals is a caring and serving community
working for the women and children. The main objective of this to reduce the
mortality rate. They aim to help as many as women every year approximately 120
million will be get help in next 5 years. They also aim to reach 50 countries
through their programs.
Sanofi India, is also a part of MDG and is trying to help women caring
and providing services through their corporate social responsibility. The
employees are constantly involved in volunteering and contributing of the women
in India. They work in collaboration with organizations like Indian Medical
Association and Pharmaceutical industry and many more.
Taste the market data and market information presented through more than
50 market data tables and figures spread over 80 numbers of pages of the
project report. Avail the in-depth table of content (TOC) & market synopsis
on “Global Maternal Health Market” Research Report – Forecast to 2023.
Table Of Contents:
1. INTRODUCTION
1.1 DEFINITION
1.2 SCOPE OF STUDY
1.2.1 RESEARCH OBJECTIVE
2. RESEARCH METHODOLOGY
2.1 RESEARCH PROCESS:
2.2 PRIMARY RESEARCH
2.3 SECONDARY RESEARCH:
3. MARKET DYNAMICS
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
….
13. COMPANY PROFILE
13.1 AGEIL THERAPEUTICS
13.2 FUJI LATEX Co
13.3 JOHNSON & JOHNSON
13.4 OKAMOTO INDUSTRIES
Continued…
Browse Complete
Report Details @ https://www.marketresearchfuture.com/reports/maternal-health-market-732
About US:
Market Research Future (MRFR), enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
According to MRFR analysis, the global virtual clinical
trials market is expected to register a CAGR of ~5.89% during the forecast
period of 2021 to 2027 and is expected to reach ~USD 11,239.0 million by 2027.
Virtual clinical trials are method of conducting clinical
research using apps, electronically monitoring devices and online social
engagement platforms. In 2020, 76% of more than 200 clinical trial sponsors
said they conducted most or all of their patient monitoring remotely, up from
only 18% of respondents the previous year, according to the 2021 State of the
Industry Report from Florence Healthcare (US), a provider of digital research
workflows and remote site access. This exponential increase in number of
clinical trials monitored digitally is expected to increase the growth of
global virtual clinical trials market during the forecast period.
The global virtual
clinical trials market is currently dominated by several market players.
The key players are involved in geographic expansion, acquisition, and
strategic collaborations to maintain their global footprint in the global
virtual clinical trials market. For instance, in June 2020, Tabula Rasa
HealthCare (US), a New Jersey-based company collaborated with Washington-based
health plan provider Regence (US) to virtually trial several different COVID-19
drug candidates and assess the risk of adverse drug events. Regence will
provide de-identified medical information from about 500,000 of its members to
Tabula Rasa HealthCare. Thus, an increasing number of healthcare companies
collaborating with technology companies to leverage data-driven clinical
studies for development of effective medication by monitoring trials remotely
is increasing global virtual clinical trials market size. The demand created by
pandemic for adoption of monitoring trials remotely is expected to increase the
lucrativeness of virtual clinical trials market during the forecast
period.
Get Sample Report
@https://www.marketresearchfuture.com/sample_request/10734
Regional Analysis
The market has been divided, by region, into the North
America, Europe, Asia-Pacific, and Rest of the World.
North America is anticipated to hold the largest market
share owing to availability of major players operating in the region. Medable,
Inc. (US), Oracle Corporation (US), IQVIA Holdings, Inc. (US), Syneos Health
(US), PPD, Inc. (US) and Medpace Holdings, Inc. (US) are some of the notable
companies operating in the region. Moreover, collaborative approach by
companies operating in the region were observed due to rising demand and
continuation of early phase clinical studying during the pandemic. For
instance, during October 2020, FHI Clinical Inc. (US), a contract research
organization adopted Oracle’s (US) Oracle Health Sciences Clinical One, a cloud
platform for effective study management throughout the entire drug development
lifecycle. FHI clinical also uses Oracle Argus Safety for safety case
management; Oracle Clinical Trial Management System Cloud Service to manage the
research portfolio; and Oracle ClearTrial Cloud Service to manage projects.
Thus, increasing adoption of cloud-based platforms by contract research
organizations operating in the region are anticipated to fuel the growth of
virtual clinical trials market. The virtual clinical trials market in North
America is divided into the US and Canada.
European virtual clinical trials market has been categorized
into Germany, France, the UK, Italy, Spain, and the rest of Europe. Europe is
anticipated to hold the significant market share owing to investment activities
related to clinical trials in the region and support from government for
R&D. For example, Parexel International Corporation (US) in November 2020
announced a strategic partnership between its Early Phase Clinical Unit
(Germany) and Clinical Trial Center (CTC) North, a full-service CRO located at
the University Medical Center Hamburg-Eppendorf (Germany). Parexel intends to
roll-out and implement eSource system ClinBase at CTC North to drive
efficiency. An increasing number of research institutes partnering with leading
clinical trial services provider to accelerate development of products for
different conditions such as cancer, COVID-19 and other disorders is expected
to fuel growth of virtual clinical trials market during the forecast period.
Moreover, ongoing research studies being converted to virtual mode are expected
to increase the demand for IT services, thereby generating opportunities for IT
companies to access virtual clinical trials market. Thus, long-term
partnerships among research institutes and service providers to accelerate
ongoing research studies is anticipated to increase the lucrativeness of
virtual clinical trials market in the region during the forecast period.
The virtual clinical trials market in Asia-Pacific has been
segmented into Japan, China, India, South Korea, Australia, and the rest of
Asia-Pacific. The growth of virtual clinical trials market in Asia-Pacific is
anticipated to witness rapid growth during the forecast period owing to
increasing number of memorandum signed by governmental agencies to promote
research activities. For example, India and the UK announced a new memorandum
of understanding in November 2020 between the Central Drugs Standard Control
Organisation (India) and the UK Medicines and Healthcare Products Regulatory
Agency. This memorandum is expected to increase bilateral regulations, sharing
of information to control the trade of unlicensed products and 10-year roadmap
for bilateral cooperation on the COVID-19 vaccine. Moreover, during April 2020
the Chinese government issued a plan of action in order to promote virtual
clinical trials. Apart from support from governmental agencies to promote
decentralized clinical trials, pharmaceutical companies operating in the
Asia-Pacific are adopting to report clinical trials data virtually. For
instance, on October 21, 2021 Shionogi & Co., Ltd (Japan) presented results
of its investigational oral antiviral drug for COVID-19 at the International
Society for Influenza and Other Respiratory Virus Diseases, World Health
Organization Virtual Conference. Thus, increasing support for R&D through
multilateral memorandum of understanding among government bodies and need to
present data virtually is expected to propel the growth of virtual clinical
trials market in the region.
The virtual clinical trials market in Rest of the World has
been divided into the Middle East, Africa and Latin America. Africa contributed
to less than 2% of the total number of clinical trials during 2020. The African
Academy of Sciences (AAS) launched the Clinical Trials Community online
platform during November 2020. The launch of such online platform promotes the
progression of intra-African collaboration around clinical trials.
Segmentation
The global virtual clinical trials market has been segmented
based on study type, phase, and indication.
The market, based on study type, has been divided into
interventional, observational and others. The interventional segment is likely
to hold maximum market share in the global virtual clinical trials market owing
to its larger utility and recruitment of patients for testing novel drugs.
The virtual clinical trials market based on phase has been
segmented into Phase 1, Phase 2, Phase 3 and Phase 4. The Phase
1 segment is likely to hold significant share in the market as every clinical
trial study proceeds through Phase 1.
The virtual clinical trials market based on indication has
been segmented into oncology, cardiovascular, immunology, gastrointestinal,
respiratory, endocrinology, ophthalmology and others.
The oncology segment is likely to hold the largest share in the
market due to larger number of clinical trials focused on finding treatment
options for cancer.
Access full report @ https://www.marketresearchfuture.com/reports/virtual-clinical-trials-market-10734
About US:
Market Research Future (MRFR), enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Market Highlights
According to MRFR analysis, the global low-pressure liquid
chromatography market is expected to register a CAGR of ~3.6% from 2020 to
2027.
The global low-pressure liquid chromatography market is
driven by the expansion of research facilities across the globe, increasing
government funding in the healthcare sector, and the rising population
diagnosed with hereditary disorders such as Parkinson's disease, sickle cell
disease, and Alzheimer's disease. In addition, increasing demand for DNA-based,
RNA-based, and protein-based medicines to treat hereditary problems has created
opportunities for the market players. Additionally, the low-pressure liquid
chromatography systems segregate proteins, nucleic acids, and other small &
complex molecules involved in several biological procedures. Moreover, the
low-pressure liquid chromatography is also utilized to separate two polar
organic solutes, screen drugs in sports, and segregate a wide range of
hypersensitive and nonsteroidal anti-inflammatory drugs. The rise in the
adoption of such biological extraction methodologies is expected to augment the
low-pressure
liquid chromatography market.
Get
Sample Report @https://www.marketresearchfuture.com/sample_request/10724
Key Players
Some of the key players in the global low-pressure liquid
chromatography market are Novasep (France), LEWA GmbH (Germany), GALAK
Chromatography Technology Co., Ltd (China), Biolinx Labsystems (India), and
Bio-Rad Laboratories, Inc. (US).
Segmentation
The global low-pressure liquid chromatography market is
segmented into components and end user. Based on component, the market has been
segregated into instruments, consumables, and services. The instruments segment
held a considerable market share in 2020. The demand for low-pressure liquid
chromatography is the largest contributor to the global market due to its high
engagement in research facilities to derive COVID-19 vaccines and other
microbial infection treatments. In addition, the ongoing innovation of drugs
and treatment for chronic diseases are strengthening the demand for
low-pressure liquid chromatography products.
Based on end user, the global low-pressure liquid
chromatography market has been classified as pharmaceutical companies,
biotechnology companies, research laboratories, and academic institutions.
Pharmaceutical companies held a considerable share of the market in 2020, owing
to the high demand for medicines across the globe due to the spread of deadly
coronavirus and chronic diseases. Additionally, increasing public and private
investments in drug development and growing funding in the pharmaceutical
sector to transform the research and production facilities are expected to drive
the segment in the projected timeline.
The industry providers are involved in technological
enhancement, product development, expansion of distribution network, investment
public relations, and mergers & acquisitions to expand their global
footprint. The industry players are planning to adopt business plans such as
the development of advanced low-pressure liquid chromatography systems to
provide accurate and efficient test and extraction results. Additionally, the
global market players aim to invest in the developing countries owing to
supportive government policies, economic labor costs, and the high availability
of raw materials. These factors will strengthen the market development and will
propel the market demand in the projected period.
Regional Analysis
North America is projected to dominate the low-pressure
liquid chromatography market in the forecast period, owing to the presence of a
large number of market players, increasing government fundings, expansion in
research facilities, extensive distribution network, and growing usage of
chromatography in drug development. Furthermore, the key players are involved
in business approaches such as collaborations, mergers, technical partnerships,
government alliances, and an increasing number of clinical trials are a few of
the factors propelling the market growth. Europe embraces the second-largest
position in the low-pressure liquid chromatography market due to the increasing
development, manufacturing, and commercialization of therapeutics, increasing
establishment of analytical and biotechnology laboratories across the region.
Likewise, increasing the utilization of molecular diagnosis for forensic
investigation is driving the European low-pressure liquid chromatography
market. The industry players provide high-quality products and superior
after-sales service to gain an edge over the existing industry providers. These
business parameters are expected to propel the low-pressure liquid
chromatography market in the anticipated time.
Asia-Pacific is likely to hold the major market share over
the assessed timeline due to the transformation in pharmaceutical
infrastructure, high investment in the modernization of research laboratories,
rising demand for generic and advanced medicines across the region, and increasing
awareness about genetic and molecular drugs. Moreover, the rising demand for
environmental and chemical analysis devices and equipment is driving the
Asia-Pacific low-pressure liquid chromatography market.
Furthermore, the development of the market in the Rest of
the World has been gaining market share in the low-pressure liquid
chromatography market over the last few years due to the growing interest of
investors in the local research facilities, supportive government regulations,
establishment of technically advanced pharmaceutical infrastructure and growing
research activities on the extraction of molecular components such as proteins,
RNA, DNA, and other complex molecules. These aspects are likely to fuel the
market growth over the assessed period.
Access full report @ https://www.marketresearchfuture.com/reports/low-pressure-liquid-chromatography-market-10724
About US:
Market Research Future (MRFR), enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting
Services.
Nitrile rubber is more resistant to oils, chemicals, and
acids than natural rubber and has greater strength. Gloves made from latex are
less puncture-resistant as compared to nitrile gloves. Similarly, gloves made
from vinyl are less chemical resistant as compared to nitrile gloves. Nitrile
is now the choice material for manufacturing disposable mechanics gloves and
other industrial-grade gloves that are used in risky work environments where
all kinds of sharp objects are in use.
The global disposable
nitrile gloves market is growing steadily. Factors that influence the
disposable nitrile gloves market are increasing preference for use at
workplaces across several industries and growing awareness on prevention of
healthcare-associated infection (HAI).
Get Sample Report @https://www.marketresearchfuture.com/sample_request/10675
Segment Analysis
The global disposable nitrile gloves market has been divided
based on type and application.
Based on type, the market isbifurcated into powder-freeand
powdered. The powder-free segment dominated the market in 2020 and is projected
to be a faster-growing segment during the forecast period.This is attributed to
thehigh strength and durability powder-free disposable nitrile gloves, making
them useful for manufacturing industries where workers may encounter materials
made of glass and metal.
Based on application,the global disposable nitrile gloves
market is segmented into medical and non-medical. The medical segment
dominated the market in 2020 and is projected to record a faster growth rate
during the forecast period.The disposable nitrile gloves are used in healthcare
facilities primarily for examining patients and are worn by healthcare workers
and sometimes patients as well.
Regional Analysis
Based on region, the market is studied acrossthe Americas,
Europe, Asia-Pacific, and the Middle East & Africa. The Americas accounted
for the largest market share in 2020 and is anticipated to dominate the global
disposable nitrile gloves market during the forecast period. However,
Asia-Pacific is projected to register the highest CAGR during the forecast
period.
The Americas is expected to dominate with the largest market
share due to a well-developed healthcare sector, high imports of disposable
nitrile gloves, and the increasing number of healthcare-related infections over
the past decade. In the region, modern healthcare employs various types of
invasive procedures and devices to treat patients and facilitate their recovery
process. Healthcare-related infections in the region are commonly associated
with devices such as catheters, ventilators, and surgical operations. The
market in the Americas has been divided into North America and Latin
America.The market in North America has been divided further into the US and
Canada. The US accounts for the largest market share in the North American
disposable nitrile gloves market. In the US, the Centers for Disease Control
and Prevention (CDC) has been working to monitor and prevent such
hospital-related infections, as they pose serious health concerns.The
availability of government regulations regarding imports of essential goods and
a large volume of imports are the drivers for the disposable nitrile gloves
market in the region.For instance, an increase of 35.7% was observed in the
import of medical gloves in Canada in May 2020 compared to April 2020. A
considerable portion of demand for disposable nitrile gloves is expected to
come from new industries that are emphasizing implementing policies for wearing
disposable gloves for grocery clerks and e-commerce packing & delivery
staff.
Europe is the second-largest market for disposable nitrile
gloves. The growing demand for disposable nitrile gloves in Europeis attributed
to the increasing utility of disposable nitrile gloves across major industries,
including healthcare, pesticide, petrochemical & auto motive, government
initiatives towards promoting safer work conditions, and more eco-friendly
nitrile gloves. The increasing prevalence of healthcare-associated infections
in European countries is also one of the major factors responsible for the
rising demand for disposable nitrile gloves in the region. According to the
European Centre for Disease Prevention and Control, the average prevalence of
hospital-acquired infections is estimated to be 7.1% in European countries.
Asia-Pacific is the fastest-growing market for disposable
nitrile gloves. The growth can be primarily ascribed to the presence of major
manufacturers of the disposable nitrile gloves industry in the region, such as
VRG Khai Hoan JSC (Vietnam), Top Glove (Malaysia), Hartalega Holdings Berhad
(Malaysia), Kossan Rubber Industries Ltd. (Malaysia), Sri Trang Gloves
(Thailand), and Supermax Corporation Berhad (Malaysia). Malaysia, Vietnam, and
Thailand are the key manufacturers of disposable nitrile gloves. In addition,
the exports of disposable nitrile gloves to major markets across the world make
Asia-Pacific the fastest growing regional market in the world. About 70 billion
gloves manufactured in the region are imported annually by the US alone.
Moreover, the easy accessibility to raw materials and cheap labor make the
conditions favorable for the growth of the disposable nitrile gloves industry
in the region.
Countries in the Middle East and Africa, such as Algeria,
Egypt, and Iraq, have made substantial improvements in developing their health
care systems.Factors such as improvement in healthcare infrastructure in
low-income countries of the region and high risk of infectious diseases are
creating demand for nitrile gloves. Moreover, increasing awareness of
hospital-associated infections and promoting the safe use of examination gloves
are expected to drive the demand for disposable nitrile gloves in the region.
Access full report @ https://www.marketresearchfuture.com/reports/disposable-nitrile-gloves-market-10675
Key Findings of the Study
About US:
Market Research Future (MRFR), enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
According to Market Research Future (MRFR), the global freeze-drying
equipment market is expected to procure the market value of USD 3,831.91
million, thriving at a CAGR of 11.82% by 2027.
The freeze-drying equipment is likely to gain prominence in
the food and pharmaceutical industries due to its ability to maintain a
product's physical and chemical properties, which can fuel the freeze-drying
equipment market 2020. The demand for extended shelf-life for food is expected
to increase the prominence of freeze-drying
equipment market and the market in the forecast period. Furthermore,
increased food transport is projected to grow the requirement of food
preservation, which is anticipated to surge the demand for the equipment and
expand the market during the forecast period. Apart from these, the military
and defense sector is likely to increase the demand for freeze-dried equipment
owing to the rising usage of freeze-dried plasma in the battlefield, which can
augment the market.
On the other hand, the growing utilization of alternative
drying techniques in the pharmaceutical and biotechnology industries can impede
the market growth. Nonetheless, the increasing technological development along
with prior stated factors, are projected to counter the restraining factors and
boost the market.
Get Sample Report
@https://www.marketresearchfuture.com/sample_request/7848
Key Players
Some of the renowned players of the global market for
freeze-drying equipment market are Hosokawa Micron B.V. (Netherlands), Azbil
Telstar, S.L.U. (Spain), Industria Macchine Automatiche S.P.A.
(Italy),Millrock Technology, Inc. (U.S.), Tofflon (China), S.P. Scientific
(U.S.), and ZIRBUS Technology GmbH (Germany).
Market Segmentation
The segmental analysis of the global freeze-drying equipment
market is done by type, product, and application.
The type-based segments of the global freeze-drying
equipment market are industrial, laboratory, and general-purpose freeze
dryers.
The product-based segments of the global freeze-drying
equipment market are benchtop freeze dryers and mobile freeze dryers.
The application-based segments of the global freeze-drying
equipment market are biotechnology, pharmaceuticals, food processing, surgical
procedures, and others. Among all segments, the biotechnology segment is
anticipated to acquire the largest market share during the forecast period
owing to the increasing opportunities in the biotechnology industry along with
the rising number of fatal diseases across the world.
Regional Analysis
Based on the region, the global freeze-drying equipment
market is segmented into the Americas, Europe, Asia-Pacific, and the Middle
East & Africa.
As per the assessment, the global market for global
freeze-drying equipment is anticipated to be dominated by the North Americas
owing to the significant role played by the well-renowned pharmaceutical
sector. Furthermore, the rising demand for processed food is likely to play an
important role in expanding the regional market during the review period.
Strong economies like the U.S. and Canada are anticipated to play a salient
role in developing the regional market.
Europe market is anticipated to be the second-largest market
during the forecast period owing to the presence of the lucrative
pharmaceutical industry booming in the region. The majority of the market share
is held by countries such as the UK, France, and Germany. Germany is
anticipated to dominate the regional market during the forecast period.
The APAC region is likely to witness substantial market
share during the forecast period owing to the prospering food industry.
Further, the increasing demand for food preservation is anticipated to further
underpin the market in the coming period. The presence of evolving economies
like India and China are predicted to play an important role in developing the
market due to the rapid rise in population.
The M.E.A. region is anticipated to witness steady growth
during the review period. The Middle East countries are likely to dominate the
region owing to the on-going development like industrialization.
Access full report @ https://www.marketresearchfuture.com/reports/freeze-drying-equipment-market-7848
About US:
Market Research Future (MRFR), enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports
(3R), Continuous-Feed Research (CFR), and Market Research & Consulting
Services.
Real-time PCR (qPCR) Market: Increasing prevalence of target
diseases and technological advancements such as the development of high
performance and superior qPCR are anticipated to boost the market at a healthy
CAGR of ~8.92% from 2021 to 2027
Market Highlights
According to MRFR analysis, the global Real-Time
PCR (Qpcr) Market is expected to register a CAGR of ~8.92 from 2021 to 2027
and hold a value of ~USD 8,398.55 million by 2027.
The global real-time PCR (qPCR) market is driven by
continued efforts by PCR manufacturers to develop novel kits and systems to be
used in molecular diagnostic testing. For example, in January 2019, Qiagen
N.V.(Germany) developed next-generation qPCR systems, which were launched in
April 2020. The new system isprojected to offer highly automated workflowand
quick turnaround time. This factor is likely to provide a significant
competitive advantage to the company, fueling the overall market growth of
Real-time PCR (qPCR).
Get Sample Report
@https://www.marketresearchfuture.com/sample_request/10672
Key Players
Some of the key players in the global real-time PCR
(qPCR)marketareABL SA Group (Luxembourg), Agilent Technologies, Inc. (US),
Analytik Jena AG (Germany), BD (US), Bio-Rad Laboratories, Inc. (US), F.
Hoffmann-La Roche Ltd (Switzerland), Fluidigm Corporation (US), Lumex Instruments
(US), Primerdesign Ltd (UK), QIAGEN (Germany), Takara Bio Inc. (Japan), Thermo
Fisher Scientific (US), TOYOBO Inc. (Japan), and Vela Diagnostics (Singapore).
Severalglobal and local market players dominate the global
real-time PCR (qPCR) market, contributing to a substantial market share. The
prominent players are engaged in organic and inorganic strategies such
asagreements, new product development & launches, and approval from
government authorities, joint ventures, mergers & acquisitions, and partnerships
to sustaintheir market positions.For instance, in October 2017, AOAC
International (US), independent standards developing organization certified
Bio-Rad Laboratories (US) iQ-Check Real-time PCR (qPCR) Kit as the Official
Method of Analysis for Salmonella species identification in raw meat. Such
recognition to the company is anticipated to boost the market growth.
Regional Analysis
Based on region, North America is expectedto dominate the global real-time PCR
(qPCR) market in 2020 due to the rising adoption of novel and innovative
genomic analysis products and the availability of R&D grants.
The high prevalence of chronic & infectious diseases
coupled with increasing awareness among patients about early diagnosis of
diseases is propelling the market growth.
Europe is expected to hold the second-largest position in
the global real-time PCR (qPCR) market in 2021. Key factors attributing to the
market growth are increasing adoption of real-time PCR (qPCR) to diagnose and
estimate disease-causing microbes, with increasing product availability
forconsumers.
Furthermore, the growth in the rest of the world real-time
PCR (qPCR) market is attributed to the technological product advancements and
high penetration of advanced healthcare technologies in research organizations
focused on adopting real-time PCR (qPCR) as a testing methodin Saudi Arabia,
the UAE, and the other Middle Eastern and African countries. Developing
countries such as Brazil, Colombia, and Argentina, among others in Latin
America, are also key contributors to the growth of the market.
Access full report @ https://www.marketresearchfuture.com/reports/real-time-pcr-qpcr-market-10672
Segmentation
The global real-time PCR (qPCR) market has been segmented
into type, product, source, and application.
By product, the market has been segregated into reagents
& consumables, instruments, and software & services. The reagents &
consumables segment is expected to hold a considerable share of the market in
2021. Increasing adoption of reagents and consumables
Based on application,the real-time PCR (qPCR)market is
classified into clinical, research, forensics, and others. The clinical segment
held the largest market share in 2020. Some of the key factors attributing to
the market growth include the increasing adoption of Real-time PCR (qPCR) to
diagnose and estimate disease-causing microbes and other clinical ailments.
On the basis of the end user,the real-time PCR (qPCR) market
is segmented into hospitals & diagnostic centers, research laboratories
& academic institutes, pharmaceutical & biotechnology companies,
clinical research organizations, and forensic laboratories. The research
laboratories & academic institutes segment accounted for the major share in
2020 among the end user segment of the global real-time PCR (qPCR) market due
tothe increasing number of research laboratories and rising application of
Real-time PCR (qPCR) in sectors such as stem cell research and genetic disease
and oncology research.
Browse Complete
Report Details @ https://www.marketresearchfuture.com/reports/real-time-pcr-qpcr-market-10672
About US:
Market Research Future (MRFR), enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact us:
Market Research Future (part of
Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
Market Highlights
According to MRFR analysis, Global Remdesivir
(COVID 19) Market is expected to register a CAGR of 31.2% during the
forecast period of 2020 to 2027 and reach USD 10,119.99 Million by 2027.
Remdesivir is an antiviral drug. FDA approved the remdesivir
drug in April 2020 for the clinical trials for COVID 19 treatment. Studies have
shown that around 46% of US patients have been recovered from COVID 19 quickly.
The growth of the global Remdesivir (COVID 19) market can be
contributed to the growing need for rescue medication, including remdesivir
drugs, due to the outbreak of COVID-19 globally. Furthermore, the rising
geriatric population is also expected to fuel market growth during the forecast
period. However, the availability of various substitutes for Remdesivir (COVID
19), are expected to restrain the growth of the global Remdesivir (COVID 19)
market.
Get Sample Report
@https://www.marketresearchfuture.com/sample_request/10141
Gilead Sciences, Inc., Bright Gene, Hainan Haiyao, Cipla,
Pfizer, Merck, Cayman Chemical, Kelun Pharma, Hunan Warrant Pharmaceutical, Dr.
Reddy's Laboratories, and others are some of the major market leaders in
Remdesivir. Organic strategies such as product launches, mergers, and
collaborations are used by the companies operating on the market to boost their
share. Gilead Sciences, Inc., for instance, has announced it will donate 1.5
million doses of the medication for compassionate use. The company has also
started manufacturing liquid and freeze-dried ways to improve supplies.
UK-based AstraZeneca has approached rival drug maker Gilead Sciences about a
potential merger.
Regional Analysis
The market has been divided, by region, into the Americas,
Europe, Asia-Pacific, and the Middle East & Africa. The Americas region
held the largest market in 2020, owing to the growing cases of COVID 19 in the
region. The remdesivir (COVID 19) market in the Americas has further been
branched into North America and Latin America, with the North American market
divided into the US and Canada. The European remdesivir (COVID 19) market has
been categorized as Western Europe and Eastern Europe. The Western European
market has further been classified as Germany, France, the UK, Italy, Spain,
and the rest of Western Europe. The remdesivir (COVID 19) market in
Asia-Pacific has been segmented into Japan, China, India, South Korea,
Australia, and the rest of Asia-Pacific. Due to the increasing rate of COVID 19
cases, the market in Asia-Pacific is expected to be the fastest-growing. The
remdesivir (COVID 19) market in the Middle East & Africa has been divided
into the Middle East and Africa.
Key Players
Some of the key players in the global remdesivir (COVID 19)
market are Gilead Sciences, Inc. (US), Mylan (US), Cipla (India), Hetero Labs
(India), and Jubilant Life Sciences (India)
Segmentation
Global Remdesivir (COVID 19) market has been segmented based
on the Dosage and Distribution Channel.
Based on the dosage, the global remdesivir (COVID 19) market
has been segmented into 5mg, 10mg, 50mg, and 100mg. The 100 mg segment is
expected to hold the largest market share owing to rise in COVID 19 and 100 mg
is specifically used for older people and COVID 19 is affecting more in older
people
On the basis of distribution channel, the market has been
segmented into hospitals and drug stores. The hospitals are expected to hold a
major market share owing to government regulation i.e. the drug can be given in
the hospitals only.
Browse Full Report Details @ https://www.marketresearchfuture.com/reports/remdesivir-market-10141
About US:
Market Research Future (MRFR), enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact us:
Market Research Future (part of
Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
The global Dry Mouth
Relief Marketis growing at a
rapid pace. The market growth is primarily driven by the growing prevalence of
xerostomia, disorders related to dry mouth, and side effects of some diseases
such as HIV, Sjogren’s syndrome, and rheumatoid arthritis. The market appears
to be well-developed due to the availability of many novel medicines &
therapies to treat symptoms of the condition.
Moreover, spreading awareness among people about the disorder and the
availability of novel effective treatment accelerate the growth of the market.
According to Market Research Future (MRFR), the global dry mouth relief market
is poised to reach USD 2,777.14 MN by 2026, growing at 4.10% CAGR during the
forecast period (2020 – 2026).
Dehydration, Anxiety & stress, and increased smoking as a result of
changing lifestyles lead to symptoms of dry mouth. Besides, the availability of therapeutic
medicines fuels market growth. Additionally, factors such as the increasing
patient population and the rise in the global economy push market growth.
Technological advances in medical science that are led by substantial R&D
investments foster the market growth excellently.
On the flip
side, large unmet needs and drug resistance cases are anticipated to hamper the
market growth during the projected period. Nevertheless, advances in drug
development & manufacturing techniques would support market growth
throughout the analyzed period, presenting more advanced and cost-effective
treatments.
Get Sample Report @https://www.marketresearchfuture.com/sample_request/9581
Dry Mouth Relief Market - Segmentations
The report is segmented into
three dynamics;
By Type : Mouthwash, Spray,
Lozenges, Gel, and others.
By Distribution
Channel:
Pharmacies,
E-Commerce, Supermarkets, and others.
By Regions : Americas,
Europe, Asia Pacific, and Rest-of-the-World.
Dry Mouth Relief Market - Regional
Analysis
North America dominates the global dry mouth relief market. The largest
market share attributes to the rising patient population suffering from dry
mouth or xerostomia in the region. Moreover, the well-spread awareness
regarding the disease and the availability of treatments xerostomia in the
region drive the market growth. Also, factors such as favorable reimbursement
scenarios and substantial healthcare expenditure substantiate regional market
growth.
Furthermore, wide uptake of advanced technologies acts as a key growth driver
for the regional market. The North American dry mouth relief market is
estimated to retain its leading position throughout the assessment period.
Europe stands second in the global dry mouth relief market. The market
growth is predominantly driven by the growing prevalence of xerostomia,
disorders related to dry mouth, and risk factors such as HIV, Sjogren’s
syndrome, and rheumatoid arthritis, among others in the region. The resurging
economy in the region undoubtedly acts as a key driving force for the regional
market.
Additionally, the presence of major industry players such as Fresenius
(Germany), Sunstar (Switzerland), Johnson & Johnson Services, Inc. (UK),
Sanofi (France), and GlaxoSmithKline PLC (UK), in the region influences the
market growth. The European dry mouth relief market is projected to create a
substantial revenue pocket during the review period.
Asia Pacific region is a promising market for dry mouth relief products.
The market growth is led by a huge population and the availability of low-cost
drugs for the treatment in the region. Moreover, the growing healthcare sector
and large unmet needs in the region fostered the growth of the market. China
and India contribute to the growth of the regional market majorly.
Besides, Vietnam, Thailand, and Malaysia, among other Southeast Asian
countries, provide impetus to the regional market growth. The APAC dry mouth
relief is expected to emerge as the fastest-growing market from 2020 to 2026.
Dry Mouth Relief Market - Competitive Analysis
Highly competitive, the global dry mouth relief market appears
fragmented due to the presence of several well-established players. To gain a
larger competitive share, industry players incorporate strategic initiatives
such as mergers & acquisitions, collaborations, expansion, and product/
technology launch. They make substantial investments to drive R&D clinical
trials required for the development of breakthrough drug discoveries.
Major Players:
Players leading the global dry mouth relief market include Procter &
Gamble (US), Johnson & Johnson Services, Inc. (UK), GlaxoSmithKline Plc
(UK), Colgate-Palmolive (US), 3M (US), Sanofi (France), Bioxtra, Sunstar
(Switzerland), Mars, Incorporated (US), Dr. Fresh (California), Prestige
Consumer Healthcare, Inc. (US), Xlear (US), Oral Biotech (US), Mission
Pharmacal Company (US), Therabreath (California), Fresenius (Germany), and
Wisconsin Pharmacal Company (US), among others.
Industry/Innovation/ Related News:
February
13, 2020 ---- Sunstar Group, a
global leader in oral health & the whole body health, launched its new Gum
Hydral dry mouth relief products to address a clear patient need, as most dry
mouth sufferers. The new product line has an advanced OTC formulation that
works like natural saliva to deliver multisymptom relief. Gum Hydral features
advanced moisturizing and hydrating ingredients that work like natural saliva
for multisymptom relief.
Browse
Complete Report Details @ https://www.marketresearchfuture.com/reports/dry-mouth-relief-market-9581
About
US:
Market Research Future (MRFR), enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact
us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
The well-established global onychomycosis market is growing pervasively.
Rising prevalence of onychomycosis and per capita healthcare expenditure
worldwide are the major driving forces behind the growth of the market.
Besides, factors such as the surge in the diabetic patient population and the
increasing occurrences of peripheral artery disease (PAD) impact the market
growth positively.
Market Research Future (MRFR), in its recently published onychomycosis
marketreport, asserts that the market is estimated to rise to USD 7,912.5 MN
by 2025. MRFR also mentions that this appreciation of the market value would be
registered at 6.28% CAGR during the assessment period (2019-2025). The
availability of therapeutic medicines is blowing up the market size, providing
growth opportunities to the market players.
Get Sample Report
@https://www.marketresearchfuture.com/sample_request/1340
Drivers
& Restraints:
Some of the other major factors substantiating the market growth include
improving economic conditions worldwide that enable access to quality and
improved healthcare. Also, the changing or unhealthy lifestyle and pollution
that is led by the growing urbanization & industrialization propel the
growth of the onychomycosis treatment market globally. Additionally,
technological advancements, backed by the substantial investments made in the
R&D activities, foster the market growth excellently.
On the other hand, the lack of awareness about onychomycosis, alongside
the availability of treatments, is projected to inhibit the market growth over
the anticipated period. Also, factors such as unmet clinical needs,
side-effects associated with onychomycosis treatment medicines, drug
resistance, and complications occurring during the treatment are expected to
impede the market growth during the review period.
Global Onychomycosis Market- Segments
For enhanced understanding, themarket is segmented into four
key dynamics.
By
Type : Distal Subungual
Onychomycosis (DSO), White Superficial Onychomycosis (WSO), Proximal Subungual
Onychomycosis (PSO), Candida Onychomycosis, and others.
By
Treatment Type : Drug Treatment,
Topical Therapy, and others.
By
Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and others.
By
Regions : Europe, North
America, APAC, and Rest-of-the-World.
Global Onychomycosis Market- Regional analysis
North America holds the largest share in the global onychomycosis market.
The market growth attributes to the increasing number of patients suffering
from immune diseases and the presence of a huge geriatric population. Also, the
increasing prevalence of onychomycosis and peripheral artery disease acts as a
major driving force for the market growth. Besides, factors such as the
presence of key market participants, sophisticated healthcare infrastructure,
and rising per capita healthcare expenditure contribute to the regional market
growth significantly.
Europe stands second in the global onychomycosis market. The
onychomycosis market size in the region is majorly growing due to the rising
geriatric population and the increasing burden of diabetes and growing
occurrence rates of onychomycosis. Also, flourishing pharmaceutical industries
in European countries such as the UK, Germany, France, and Spain, significantly
contribute to the onychomycosis treatment market in the region.
Furthermore, factors such as the rising per capita income and strong
healthcare penetration, and the availability of advanced treatment facilities
& skilled medical professionals drive the growth of the regional market at
a large scale. Also, the government support for research & development
plays a major role in the development of European onychomycosis markets.
Asia Pacific has emerged as a rapidly progressing market for
onychomycosis due to the rising prevalence of various skin infections. Markets
in China and India backed by the vast population and the availability of
low-cost medications to treat Onychomycosis treatment foster the market growth
in the region. Moreover, the rapidly growing healthcare sectors, coupled with
the large unmet needs, provide impetus to the market growth.
Global Onychomycosis Market- Competitive Analysis
Highly competitive, the global onychomycosis market appears to be
fragmented due to the presence of a large number of players. The increase of
spurious and counterfeit medicines has opened doors for new drug development
and opportunities for a new market leader. To gain a larger competitive advantage,
these players incorporate strategies such as mergers & acquisitions,
expansions, collaborations, and product/technology launch.
Major Players:
Some of the eminent leaders in the global Onychomycosis market include
Pfizer, Inc. (the US), Novartis AG (Switzerland), Galderma Laboratories
(Switzerland), Moberg Pharma AB (Sweden), Bausch Health Sciences (Canada), Dr.
Reddy's Laboratories Ltd (India), Merz Pharma (Germany), Medimetriks
Pharmaceuticals, Inc. (US), Kaken Pharmaceutical Co., Ltd. (Japan), GlaxoSmithKline
plc (UK), Taro Pharmaceuticals Industries Ltd. (Israel), and Johnson &
Johnson Services, Inc. (US), among others.
Industry/Innovations/Related News:
April 20, 2020 ---- Novan, Inc.
(the US), a clinical-stage biotechnology company, announced its collaboration
with a US-based full-service investment bank H.C. Wainwright & Co., LLC.
Novan is focused on leveraging nitric oxide's natural antiviral and
immunomodulatory mechanisms of action to treat a number of contagious skin
infection and oncovirus-mediated diseases. It is developing a topical antiviral
gel SB206 for the treatment of viral skin infections caused by the
molluscipoxvirus.
H. C. Wainwright & Co. provides end to end services like investment
banking, equity research, sales & trading as well corporate access, and
strategic advisory services. The partnership would aid in exploring and
evaluating a range of strategic and financial alternatives intended to maximize
the Company's shareholder value.
Novan's clinical and preclinical data, technology platform, and market
potential also includes its medicine SB208, which is indented for the treatment
of tinea pedis and onychomycosis. Currently, SB208 is positioned to initiate a
Phase 2 trial in onychomycosis following positive results in a Phase 2 study.
Access full report @ https://www.marketresearchfuture.com/reports/onychomycosis-market-1340
Get More Related
Report
About US:
Market Research Future (MRFR), enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact us:
Market Research Future (part of
Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America